Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Baudax Bio, Inc.BXRX · Entity 109081 | Chief Financial Officer | January 15, 2021 | January 20, 2021 |
| LIFECORE BIOMEDICAL, INC. \DE\LFCR · Entity 6447 | Chief Financial Officer | September 03, 2025 | September 04, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Baudax Bio, Inc.
Report date January 15, 2021 · Filed January 20, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 69,251 |
Ending reported balance
After 2021-01-15 transaction · row 3
3 source rows · reconciled sequenceRow 1 · 2021-01-15 · Grant · Acquired 5,000 · Balance 75,909 F1: The restricted stock units are fully vested upon grant. Row 2 · 2021-01-15 · Grant · Acquired 20,000 · Balance 95,909 F1: The restricted stock units are fully vested upon grant. Row 3 · 2021-01-15 · Tax withholding · Disposed 26,658 · Balance 69,251 F2: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.30 · Expires 2023-01-15 | Direct | 23,077 |
Reported balance
After 2021-01-15 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2021-01-15 · Grant · Acquired 23,077 · Balance 23,077 F3: The stock option is fully vested upon grant. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.30 · Expires 2023-01-15 | Direct | 60,000 |
Reported balance
After 2021-01-15 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2021-01-15 · Grant · Acquired 60,000 · Balance 60,000 F3: The stock option is fully vested upon grant. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted stock units are fully vested upon grant.
F2: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.
F3: The stock option is fully vested upon grant.
LIFECORE BIOMEDICAL, INC. \DE\
Report date September 03, 2025 · Filed September 04, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 336,691 |
Reported balance
After 2025-09-03 transaction · row 1
1 source rowRow 1 · 2025-09-03 · Tax withholding · Disposed 22,932 · Balance 336,691 F1: Represents number of shares withheld by the issuer to satisfy applicable tax withholding obligations in connection with the vesting and settlement of an RSU vesting. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents number of shares withheld by the issuer to satisfy applicable tax withholding obligations in connection with the vesting and settlement of an RSU vesting.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
Societal CDMO, Inc.
Report date April 08, 2024 · Filed April 08, 2024
Section 16 reporting ended · disclosed 2024-04-08. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2024-04-08 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2024-04-08 · Other · Disposed 522,699 · Balance 1,049,287 F1: Pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of February 28, 2024, by and among the Issuer, CoreRx, Inc., a Florida corporation ("Parent") and Cane Merger Sub, Inc., a Pennsylvania corporation and a wholly owned Subsidiary of Parent ("Merger Sub"), Merger Sub completed a tender offer for shares of common stock of the Issuer (each, a "Share") and thereafter merged with and into the Issuer, effective as of April 8, 2024 (the "Effective Time") with the Issuer surviving the merger. At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $1.10 per Share in cash (the "Offer Amount"), subject to any applicable withholding taxes and without interest. Row 2 · 2024-04-08 · Disposition to issuer · Disposed 1,049,287 · Balance 0 F2: Represents restricted stock units granted under an Issuer equity plan ("RSUs") granted to the Reporting Person. Each RSU represented a contingent right to receive one Share upon vesting of the RSU. Pursuant to the terms of the Merger Agreement, each outstanding RSU that was outstanding and unvested immediately prior to the Effective Time vested in full. At the Effective Time, each RSU then outstanding was cancelled and converted into a cash payment equal to the product of (A) the total number of Shares then underlying such RSU multiplied by (B) the Offer Amount, without interest and subject to any withholding of taxes. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of that certain Agreement and Plan of Merger (the "Merger Agreement"), dated as of February 28, 2024, by and among the Issuer, CoreRx, Inc., a Florida corporation ("Parent") and Cane Merger Sub, Inc., a Pennsylvania corporation and a wholly owned Subsidiary of Parent ("Merger Sub"), Merger Sub completed a tender offer for shares of common stock of the Issuer (each, a "Share") and thereafter merged with and into the Issuer, effective as of April 8, 2024 (the "Effective Time") with the Issuer surviving the merger. At the Effective Time, each issued and outstanding Share was cancelled and converted into the right to receive $1.10 per Share in cash (the "Offer Amount"), subject to any applicable withholding taxes and without interest.
F2: Represents restricted stock units granted under an Issuer equity plan ("RSUs") granted to the Reporting Person. Each RSU represented a contingent right to receive one Share upon vesting of the RSU. Pursuant to the terms of the Merger Agreement, each outstanding RSU that was outstanding and unvested immediately prior to the Effective Time vested in full. At the Effective Time, each RSU then outstanding was cancelled and converted into a cash payment equal to the product of (A) the total number of Shares then underlying such RSU multiplied by (B) the Offer Amount, without interest and subject to any withholding of taxes.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 03, 2022 Filed Feb 4, 2022 16:41 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Tax withholdingCommon Stock | 1,021 | $1.54 | $1,572.34 |
DisclosureSEC source: 0001062993-22-002640 · form4.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 544,753 F1 · shares: Shares withheld by the Company to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| January 31, 2022 Filed Feb 2, 2022 16:30 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Tax withholdingCommon Stock | 1,419 | $1.54 | $2,185.26 |
DisclosureSEC source: 0000899243-22-004168 · doc4.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 545,774 F1 · shares: Shares withheld by the Company to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| January 20, 2022 Filed Jan 24, 2022 21:30 UTC | Societal CDMO, Inc. REPH · Entity 92137 | GrantStock Option (Right to Buy) · Derivative | 247,788 | $0.00 Strike: $1.65 | $0.00 |
DisclosureSEC source: 0000899243-22-003084 · doc4.xml · derivative · entry 3 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 247,788 Underlying: Common Stock · 247,788 shares Expires 2032-01-20 F3 · derivative.exercise_date: The stock option vests in equal monthly installments over 48 months, beginning on February 20, 2022, subject to continued service with the Company. Read SEC document |
| January 20, 2022 Filed Jan 24, 2022 21:30 UTC | Societal CDMO, Inc. REPH · Entity 92137 | GrantCommon Stock | 169,697 | $0.00 | $0.00 |
DisclosureSEC source: 0000899243-22-003084 · doc4.xml · nonDerivative · entry 2 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 547,193 F2 · shares: These restricted stock units will vest in four equal annual installments beginning on January 20, 2023, subject to continued service with the Company. Read SEC document |
| January 20, 2022 Filed Jan 24, 2022 21:30 UTC | Societal CDMO, Inc. REPH · Entity 92137 | GrantCommon Stock | 39,604 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000899243-22-003084 · doc4.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 377,496 F1 · price: On January 20, 2022, the Compensation Committee of the Board of Directors of the Company determined that performance- vesting criteria were met with regard to 39,604 performance- based restricted stock units granted in a prior year, which were converted into 39,604 shares of common stock on a one- for-one basis. Read SEC document |
| January 20, 2022 Filed Apr 4, 2022 17:25 UTC | Societal CDMO, Inc. SCTL · Entity 92137 | Tax withholdingCommon Stock | 13,306 | $1.65 | $21,954.90 |
DisclosureSEC source: 0001062993-22-009512 · form4.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 533,887 F1 · shares: Shares withheld by the Company to satisfy applicable withholding taxes upon vesting of the 39,604 performance-based restricted stock units that were previously granted as reported on the Form 4 filed on January 24, 2022. Read SEC document |
| January 18, 2022 Filed Jan 19, 2022 16:31 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Tax withholdingCommon Stock | 1,094 | $1.65 | $1,805.10 |
DisclosureSEC source: 0000899243-22-002422 · doc4.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 337,892 F1 · shares: Shares withheld by the Company to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| January 03, 2022 Filed Jan 4, 2022 21:34 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Tax withholdingCommon Stock | 979 | $1.74 | $1,703.46 |
DisclosureSEC source: 0000899243-22-000720 · doc4.xml · nonDerivative · entry 2 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 338,986 F1 · shares: Shares withheld by the Company to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| December 31, 2021 Filed Jan 4, 2022 21:34 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Tax withholdingCommon Stock | 28,730 | $1.71 | $49,128.30 |
DisclosureSEC source: 0000899243-22-000720 · doc4.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 339,965 F1 · shares: Shares withheld by the Company to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| December 15, 2021 Filed Dec 17, 2021 19:36 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Tax withholdingCommon Stock | 5,690 | $1.61 | $9,160.90 |
DisclosureSEC source: 0000899243-21-048869 · doc4.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 368,695 F1 · shares: Shares withheld by the Company to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 06:05 UTC | Societal CDMO, Inc. REPH · Entity 92137 | PurchaseCommon Stock | 50 | $1.62 | $80.90 |
DisclosureSEC source: 0000899243-21-044710 · doc4.xml · nonDerivative · entry 2 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 374,385 Read SEC document |
| November 12, 2021 Filed Nov 16, 2021 06:05 UTC | Societal CDMO, Inc. REPH · Entity 92137 | PurchaseCommon Stock | 1,162 | $1.65 | $1,916.14 |
DisclosureSEC source: 0000899243-21-044710 · doc4.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 374,335 Read SEC document |
| July 08, 2021 Filed Jul 13, 2021 06:03 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Tax withholdingCommon Stock | 5,172 | $1.96 | $10,137.12 |
DisclosureSEC source: 0000899243-21-028185 · doc4.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 373,173 F1 · shares: Shares were withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 17:04 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Tax withholdingCommon Stock | 719 | $2.30 | $1,653.70 |
DisclosureSEC source: 0001192482-21-000496 · edgar.xml · nonDerivative · entry 2 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 378,345 F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| June 05, 2021 Filed Jun 8, 2021 17:04 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Exercise / conversionRestricted Stock Units · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-21-000496 · edgar.xml · derivative · entry 3 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On June 5, 2017, the reporting person was granted 10,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On June 5, 2017, the reporting person was granted 10,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| June 05, 2021 Filed Jun 8, 2021 17:04 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Exercise / conversionCommon Stock | 2,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001192482-21-000496 · edgar.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 379,064 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| April 08, 2021 Filed Apr 12, 2021 18:58 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Tax withholdingCommon Stock | 5,172 | $3.24 | $16,757.28 |
DisclosureSEC source: 0001192482-21-000334 · edgar.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 376,564 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| February 03, 2021 Filed Feb 12, 2021 16:10 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Tax withholdingCommon Stock | 1,075 | $3.74 | $4,020.50 |
DisclosureSEC source: 0001192482-21-000145 · edgar.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 381,736 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| January 18, 2021 Filed Jan 20, 2021 19:56 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Tax withholdingCommon Stock | 1,352 | $3.03 | $4,096.56 |
DisclosureSEC source: 0001192482-21-000071 · edgar.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 382,811 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| January 15, 2021 Filed Jan 20, 2021 19:32 UTC | Baudax Bio, Inc. BXRX · Entity 109081 | GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $1.30 | $0.00 |
DisclosureSEC source: 0001192482-21-000067 · edgar.xml · derivative · entry 5 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2023-01-15 F3 · derivative.exercise_date: The stock option is fully vested upon grant. Read SEC document |
| January 15, 2021 Filed Jan 20, 2021 19:32 UTC | Baudax Bio, Inc. BXRX · Entity 109081 | GrantStock Option (right to buy) · Derivative | 23,077 | $0.00 Strike: $1.30 | $0.00 |
DisclosureSEC source: 0001192482-21-000067 · edgar.xml · derivative · entry 4 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,077 Underlying: Common Stock · 23,077 shares Expires 2023-01-15 F3 · derivative.exercise_date: The stock option is fully vested upon grant. Read SEC document |
| January 15, 2021 Filed Jan 20, 2021 19:32 UTC | Baudax Bio, Inc. BXRX · Entity 109081 | Tax withholdingCommon Stock | 26,658 | $1.30 | $34,655.40 |
DisclosureSEC source: 0001192482-21-000067 · edgar.xml · nonDerivative · entry 3 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,251 F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| January 15, 2021 Filed Jan 20, 2021 19:32 UTC | Baudax Bio, Inc. BXRX · Entity 109081 | GrantCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-21-000067 · edgar.xml · nonDerivative · entry 2 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,909 F1 · shares: The restricted stock units are fully vested upon grant. Read SEC document |
| January 15, 2021 Filed Jan 20, 2021 19:32 UTC | Baudax Bio, Inc. BXRX · Entity 109081 | GrantCommon Stock | 5,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-21-000067 · edgar.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,909 F1 · shares: The restricted stock units are fully vested upon grant. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 17:18 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Tax withholdingCommon Stock | 12,610 | $2.99 | $37,703.90 |
DisclosureSEC source: 0001192482-21-000054 · edgar.xml · nonDerivative · entry 4 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 384,163 F4 · shares: Shares withheld by the Company to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 17:18 UTC | Societal CDMO, Inc. REPH · Entity 92137 | GrantCommon Stock | 30,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001192482-21-000054 · edgar.xml · nonDerivative · entry 3 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 396,773 F3 · price: On January 8, 2021, the Compensation Committee of the Board of Directors of the Company determined that performance-vesting criteria were met with regard to 30,000 performance-based restricted stock units granted in a prior year, which were converted into 30,000 shares of common stock on a one-for-one basis. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 17:18 UTC | Societal CDMO, Inc. REPH · Entity 92137 | GrantCommon Stock | 200,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-21-000054 · edgar.xml · nonDerivative · entry 2 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 366,773 F2 · shares: These restricted stock units will vest 50% on December 31, 2021 and the remaining 50% in equal monthly installments over 24 months, subject to continued service with the Company. Read SEC document |
| January 08, 2021 Filed Jan 12, 2021 17:18 UTC | Societal CDMO, Inc. REPH · Entity 92137 | GrantCommon Stock | 36,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-21-000054 · edgar.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 166,773 F1 · shares: These restricted stock units will vest 50% on April 8, 2021 and the remaining 50% on July 8, 2021, subject to continued service with the Company. Read SEC document |
| January 02, 2021 Filed Jan 5, 2021 16:57 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Tax withholdingCommon Stock | 1,210 | $3.09 | $3,738.90 |
DisclosureSEC source: 0001192482-21-000040 · edgar.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 130,773 F1 · shares: Shares withheld by Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 20:57 UTC | Societal CDMO, Inc. REPH · Entity 92137 | GrantStock Option (right to buy) · Derivative | 116,505 | $0.00 Strike: $3.03 | $0.00 |
DisclosureSEC source: 0001192482-20-000838 · edgar.xml · derivative · entry 2 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,505 Underlying: Common Stock · 116,505 shares Expires 2030-12-15 F2 · derivative.exercise_date: The stock option vests in equal monthly installments over 48 months, beginning on January 15, 2021, subject to continued service to the Company. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 20:57 UTC | Societal CDMO, Inc. REPH · Entity 92137 | GrantCommon Stock | 79,208 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-20-000838 · edgar.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 131,983 F1 · shares: These restricted stock units will vest in four equal annual installments beginning on December 15, 2021, subject to continued service with the Company. Read SEC document |
| December 05, 2020 Filed Dec 9, 2020 17:45 UTC | Baudax Bio, Inc. BXRX · Entity 109081 | Tax withholdingCommon Stock | 4,845 | $1.14 | $5,523.30 |
DisclosureSEC source: 0001192482-20-000811 · edgar.xml · nonDerivative · entry 2 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 70,909 F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| December 05, 2020 Filed Dec 9, 2020 17:45 UTC | Baudax Bio, Inc. BXRX · Entity 109081 | Tax withholdingCommon Stock | 15,064 | $1.14 | $17,172.96 |
DisclosureSEC source: 0001192482-20-000811 · edgar.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,754 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| December 05, 2020 Filed Dec 9, 2020 17:44 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Tax withholdingCommon Stock | 7,611 | $2.30 | $17,505.30 |
DisclosureSEC source: 0001192482-20-000809 · edgar.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,775 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 16:32 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Exercise / conversionRestricted Stock Units · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-20-000455 · edgar.xml · derivative · entry 3 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,500 Underlying: Common Stock · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On June 5, 2017, the reporting person was granted 10,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On June 5, 2017, the reporting person was granted 10,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 16:32 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Tax withholdingCommon Stock | 852 | $4.95 | $4,217.40 |
DisclosureSEC source: 0001192482-20-000455 · edgar.xml · nonDerivative · entry 2 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,386 F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| June 05, 2020 Filed Jun 9, 2020 16:32 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Exercise / conversionCommon Stock | 2,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001192482-20-000455 · edgar.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,238 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 16:37 UTC | Societal CDMO, Inc. REPH · Entity 92137 | GrantStock Option (right to buy) · Derivative | 45,000 | $0.00 Strike: $16.62 | $0.00 |
DisclosureSEC source: 0001192482-20-000128 · edgar.xml · derivative · entry 2 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,000 Underlying: Common Stock · 45,000 shares Expires 2030-02-03 F2 · derivative.exercise_date: The stock option vests in equal monthly installments over 48 months, beginning on the date that is one month from the date of grant, subject to continued service to the Company. Read SEC document |
| February 03, 2020 Filed Feb 5, 2020 16:37 UTC | Societal CDMO, Inc. REPH · Entity 92137 | GrantCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-20-000128 · edgar.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,738 F1 · shares: All of the shares of common stock are represented by restricted stock units that will vest in four equal annual installments beginning February 3, 2021, subject to continued service to the Company. Vested shares will be delivered to the reporting person within 30 days following each respective vesting date. Read SEC document |
| January 27, 2020 Filed Jan 29, 2020 19:45 UTC | Baudax Bio, Inc. BXRX · Entity 109081 | Tax withholdingCommon Stock | 1,725 | $8.51 | $14,679.75 |
DisclosureSEC source: 0001192482-20-000070 · edgar.xml · nonDerivative · entry 2 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,818 Read SEC document |
| January 27, 2020 Filed Jan 29, 2020 19:45 UTC | Baudax Bio, Inc. BXRX · Entity 109081 | Exercise / conversionCommon Stock | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001192482-20-000070 · edgar.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,543 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On January 27, 2020, 6,000 performance-based restricted stock units vested, which were converted into 6,000 shares of common stock on a one-for-one basis, upon meeting certain 2019 Acute Care segment performance-vesting criteria. Read SEC document |
| January 18, 2020 Filed Jan 22, 2020 17:45 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Tax withholdingCommon Stock | 1,095 | $16.38 | $17,936.10 |
DisclosureSEC source: 0001192482-20-000052 · edgar.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,738 F1 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| January 02, 2020 Filed Jan 3, 2020 16:59 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Tax withholdingCommon Stock | 979 | $17.53 | $17,161.87 |
DisclosureSEC source: 0001192482-20-000004 · edgar.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,833 F1 · shares: Shares withheld by Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| December 05, 2019 Filed Dec 9, 2019 18:43 UTC | Societal CDMO, Inc. REPH · Entity 92137 | GrantCommon Stock | 17,283 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-19-000504 · edgar.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,812 F1 · shares: These restricted stock units will vest in full on the earlier of (i) a change of control of Recro Pharma, Inc. (the "Company") (as defined in the Company's 2018 Amended and Restated Equity Incentive Plan) or (ii) December 5, 2020, subject to continued employment with the Company. Read SEC document |
| December 05, 2019 Filed Dec 9, 2019 18:19 UTC | Baudax Bio, Inc. BXRX · Entity 109081 | GrantStock Option (right to buy) · Derivative | 66,327 | $0.00 Strike: $6.33 | $0.00 |
DisclosureSEC source: 0001192482-19-000478 · edgar.xml · derivative · entry 3 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,327 Underlying: Common Stock · 66,327 shares Expires 2029-12-05 F4 · derivative.exercise_date: The stock options will vest in equal monthly installments over 48 months, beginning on January 5, 2020, subject to continued employment with the Company. Read SEC document |
| December 05, 2019 Filed Dec 9, 2019 18:19 UTC | Baudax Bio, Inc. BXRX · Entity 109081 | GrantCommon Stock | 46,429 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-19-000478 · edgar.xml · nonDerivative · entry 2 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,543 F3 · shares: These restricted stock units are scheduled to vest 25% each on December 5, 2020, December 5, 2021, December 5, 2022 and December 5, 2023, subject to continued employment with the Company through the applicable vesting date. F2 · balance_after: Total includes common stock acquired pursuant to a special dividend issued on November 21, 2019, whereby all holders of common stock of Recro Pharma, Inc., as of November 15, 2019, received a dividend of one (1) share of the Company's common stock for every two and one-half (2.5) shares of Recro Pharma, Inc. common stock. Read SEC document |
| December 05, 2019 Filed Dec 9, 2019 18:19 UTC | Baudax Bio, Inc. BXRX · Entity 109081 | GrantCommon Stock | 36,096 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-19-000478 · edgar.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,114 F1 · shares: These restricted stock units will vest in full on the earlier of (i) a change of control of Baudax Bio, Inc. (the "Company") (as defined in the Company's 2019 Equity Incentive Plan) or (ii) on December 5, 2020, subject to continued employment with the Company. F2 · balance_after: Total includes common stock acquired pursuant to a special dividend issued on November 21, 2019, whereby all holders of common stock of Recro Pharma, Inc., as of November 15, 2019, received a dividend of one (1) share of the Company's common stock for every two and one-half (2.5) shares of Recro Pharma, Inc. common stock. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 17:19 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Exercise / conversionRestricted Stock Units · Derivative | 2,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001192482-19-000277 · edgar.xml · derivative · entry 3 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 2,500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: On June 5, 2017, the reporting person was granted 10,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. F3 · derivative.expiration_date: On June 5, 2017, the reporting person was granted 10,000 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 17:19 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Tax withholdingCommon Stock | 719 | $9.55 | $6,866.45 |
DisclosureSEC source: 0001192482-19-000277 · edgar.xml · nonDerivative · entry 2 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,529 F2 · shares: Shares withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units. Read SEC document |
| June 05, 2019 Filed Jun 7, 2019 17:19 UTC | Societal CDMO, Inc. REPH · Entity 92137 | Exercise / conversionCommon Stock | 2,500 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001192482-19-000277 · edgar.xml · nonDerivative · entry 1 Lake Ryan David · CIK 0001450325 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,248 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units convert into common stock on a one-for-one basis. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.